D. Thomas

1.3k total citations
32 papers, 981 citations indexed

About

D. Thomas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, D. Thomas has authored 32 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in D. Thomas's work include Sarcoma Diagnosis and Treatment (20 papers), Vascular Tumors and Angiosarcomas (13 papers) and Cancer therapeutics and mechanisms (5 papers). D. Thomas is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Vascular Tumors and Angiosarcomas (13 papers) and Cancer therapeutics and mechanisms (5 papers). D. Thomas collaborates with scholars based in Belgium, Netherlands and United Kingdom. D. Thomas's co-authors include Henning T. Mouridsen, Armando Santoro, A.T. van Oosterom, R. Somers, R. Sylvester, G. Blackledge, Richard Sylvester, V. Bramwell, J. Buesa and P Dombernowsky and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

D. Thomas

32 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Thomas Belgium 15 721 679 221 180 162 32 981
Dominic Cellier France 12 720 1.0× 354 0.5× 188 0.9× 151 0.8× 245 1.5× 25 1.0k
A. Lurkin France 12 736 1.0× 350 0.5× 239 1.1× 154 0.9× 238 1.5× 16 1.0k
Youn Choi Park United States 8 617 0.9× 548 0.8× 183 0.8× 199 1.1× 162 1.0× 13 1.0k
Geraldine Goss Australia 13 494 0.7× 452 0.7× 153 0.7× 141 0.8× 86 0.5× 24 819
Rafal Wierzbicki Canada 13 845 1.2× 1.1k 1.7× 160 0.7× 47 0.3× 174 1.1× 29 1.6k
J Chauvergne France 16 208 0.3× 353 0.5× 228 1.0× 55 0.3× 219 1.4× 107 833
Daniel Vorobiof South Africa 18 390 0.5× 938 1.4× 340 1.5× 54 0.3× 156 1.0× 61 1.6k
J. Fra Spain 12 528 0.7× 649 1.0× 90 0.4× 108 0.6× 83 0.5× 40 907
I. Ray-Coquard France 9 437 0.6× 352 0.5× 221 1.0× 95 0.5× 114 0.7× 28 712
Rita Lionetto Italy 20 320 0.4× 962 1.4× 228 1.0× 185 1.0× 295 1.8× 53 1.4k

Countries citing papers authored by D. Thomas

Since Specialization
Citations

This map shows the geographic impact of D. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Thomas more than expected).

Fields of papers citing papers by D. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Thomas. The network helps show where D. Thomas may publish in the future.

Co-authorship network of co-authors of D. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of D. Thomas. A scholar is included among the top collaborators of D. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Thomas. D. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steward, William P., K. Vantongelen, Jaap Verweij, D. Thomas, & A.T. van Oosterom. (1993). Chemotherapy administration and data collection in an EORTC collaborative group—Can we trust the results?. European Journal of Cancer. 29(7). 943–947. 31 indexed citations
2.
Unnik, J. A. M. van, Jean‐Michel Coindre, Ch. Albus‐Lutter, et al.. (1993). Grading of soft tissue sarcomas: Experience of the EORTC soft tissue and bone sarcoma group. European Journal of Cancer. 29(15). 2089–2093. 78 indexed citations
3.
Bramwell, V., Henning T. Mouridsen, Armando Santoro, et al.. (1993). Cyclophosphamide versus ifosfamide : a randomized phase II trial in adult soft-tissue sarcomas. 31. 31 indexed citations
4.
Schütte, J., Henning T. Mouridsen, W.P. Steward, et al.. (1993). Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma.. PubMed. 31 Suppl 2. S204–9. 20 indexed citations
5.
Verweij, Jaap, A.T. van Oosterom, R. Somers, et al.. (1992). Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. Annals of Oncology. 3. S75–S80. 18 indexed citations
6.
Somers, R., Armando Santoro, Jaco J. Verweij, et al.. (1992). Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer. 28(4-5). 855–857. 4 indexed citations
7.
Buesa, J., H.T. Mouridsen, A.T. van Oosterom, et al.. (1991). High-dose DTIC in advanced soft-tissue sarcomas in the adult. Annals of Oncology. 2(4). 307–309. 85 indexed citations
8.
Steward, William P., Jaap Verweij, R. Somers, et al.. (1991). Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group. Journal of Cancer Research and Clinical Oncology. 117(S4). S193–S197. 11 indexed citations
9.
Schütte, J., Henning T. Mouridsen, Wendy A. Stewart, et al.. (1990). Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 26(5). 558–561. 74 indexed citations
10.
Blackledge, G., A. van Oosterom, Henning T. Mouridsen, et al.. (1990). Doxorubicin in relapsed soft tissue sarcoma: Justification of phase II evaluation of new drugs in this disease. European Journal of Cancer and Clinical Oncology. 26(2). 139–141. 24 indexed citations
11.
Hurteloup, P, P. Armand, Martina Schneider, et al.. (1989). Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 25(3). 423–428. 12 indexed citations
12.
Blackledge, G., Jaap Verweij, Roland J. Fuchs, et al.. (1989). A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 25(12). 1891–1893. 5 indexed citations
13.
Verschraegen, Claire F., Ulrich R. Kleeberg, J. Mulder, et al.. (1988). Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A phase II study of the eortc malignant melanoma cooperative group. Cancer. 62(6). 1061–1065. 20 indexed citations
14.
Mouridsen, Henning T., Lars Bastholt, R. Somers, et al.. (1987). Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group. European Journal of Cancer and Clinical Oncology. 23(10). 1477–1483. 122 indexed citations
15.
Rouëssé, Jacques, et al.. (1987). Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC soft tissue and bone sarcoma cooperative group. European Journal of Cancer and Clinical Oncology. 23(9). 1413–1414. 4 indexed citations
16.
Bramwell, Vivien, Henning T. Mouridsen, Armando Santoro, et al.. (1986). Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas. Cancer Chemotherapy and Pharmacology. 18(S2). S13–S16. 14 indexed citations
17.
Somers, R., Jacques Rouëssé, A. van Oosterom, & D. Thomas. (1985). Phase II study of elliptinium in metastatic soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 21(5). 591–593. 6 indexed citations
18.
Oosterom, A.T. van, Armando Santoro, V. Bramwell, et al.. (1985). Mitomycin C (MCC) in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and Bone Sarcoma Group. European Journal of Cancer and Clinical Oncology. 21(4). 459–461. 3 indexed citations
19.
Mulder, J.H., P. Dodion, F. Cavalli, et al.. (1982). Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study. European Journal of Cancer and Clinical Oncology. 18(12). 1297–1301. 10 indexed citations
20.
Thomas, D.. (1967). The visible persuaders. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominic Cellier Breakdown of academic impact, for papers by A. Lurkin Breakdown of academic impact, for papers by Youn Choi Park Breakdown of academic impact, for papers by Geraldine Goss Breakdown of academic impact, for papers by Rafal Wierzbicki Breakdown of academic impact, for papers by J Chauvergne Breakdown of academic impact, for papers by Daniel Vorobiof Breakdown of academic impact, for papers by J. Fra Breakdown of academic impact, for papers by I. Ray-Coquard Breakdown of academic impact, for papers by Rita Lionetto
Rankless by CCL
2026